Clinical Trial Update: Omega-3 for Depression and Other Cardiac Risk Factors - 2 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Omega-3 for depression and cardiac risk factors; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Omega-3 (omega-3 fatty acids)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Depression | Phase 2 | Status: COMPLETED | Results posted: 2019-08-06